• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肢体缺血的卢瑟福分类与下肢血管重建术后临床结局的关联

Association of Chronic Limb Ischemia Rutherford Classification with Clinical Outcomes Following Lower Extremity Revascularization.

作者信息

Cieri Isabella Ferlini, Rodriguez Alvarez Adriana A, Patel Shiv, Boya Mounika, Nurko Andrea, Teeple William, Dua Anahita

机构信息

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.

出版信息

Ann Vasc Surg. 2025 Apr;113:227-234. doi: 10.1016/j.avsg.2025.01.020. Epub 2025 Jan 27.

DOI:10.1016/j.avsg.2025.01.020
PMID:39864512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11903142/
Abstract

BACKGROUND

The Rutherford Classification for chronic limb-threatening ischemia (CLTI) is used to categorize peripheral artery disease severity through history and physical examination. This study investigated whether higher Rutherford Classification correlates with worse clinical outcomes and could serve as a predictive tool.

METHODS

In this prospective single-center study, 252 patients undergoing lower extremity revascularization were followed for 3 years (2020-2023). Rutherford classification was determined at presentation. Outcomes included reintervention for stenosis/occlusion, amputation rates, and mortality. Statistical analysis used chi-squared tests for categorical data and one-way ANOVA for continuous data.

RESULTS

Higher Rutherford classifications (3-6) showed increased reoperation rates versus lower classifications (28.2% vs. 10.3%, P = 0.043), with the largest increase between classes 2 and 3 (4.7-26.8%). Amputation rates were significantly higher in classifications 4-6 vs. 0-3 (31.9% vs. 7.2%, P < 0.001), particularly between classes 4 and 5 (19.0-37.6%). Mortality rates were also higher in classes 4-6 vs. 0-3 (22.6% vs. 7.2%, P < 0.001). Rutherford Classification effectively predicts major adverse outcomes, with marked increases at specific classification transitions suggesting critical thresholds for risk stratification. Early intervention may be warranted in higher classifications. These findings support its use as a valuable prognostic tool in preoperative planning and patient counseling.

CONCLUSION

This study validates Rutherford Classification as an effective tool for predicting adverse outcomes in CLTI patients. The clear correlation between higher classifications and increased complications supports its use in clinical decision-making, risk stratification, and determining optimal timing for surgical intervention.

摘要

背景

慢性肢体威胁性缺血(CLTI)的卢瑟福分类用于通过病史和体格检查对周围动脉疾病的严重程度进行分类。本研究调查了较高的卢瑟福分类是否与更差的临床结局相关,以及是否可作为一种预测工具。

方法

在这项前瞻性单中心研究中,对252例接受下肢血管重建术的患者进行了3年(2020 - 2023年)的随访。在就诊时确定卢瑟福分类。结局包括因狭窄/闭塞进行的再次干预、截肢率和死亡率。统计分析对分类数据使用卡方检验,对连续数据使用单因素方差分析。

结果

较高的卢瑟福分类(3 - 6级)与较低分类相比,再次手术率增加(28.2%对10.3%,P = 0.043),其中2级和3级之间增加幅度最大(4.7% - 26.8%)。4 - 6级的截肢率显著高于0 - 3级(31.9%对7.2%,P < 0.001),特别是4级和5级之间(19.0% - 37.6%)。4 - 6级的死亡率也高于0 - 3级(22.6%对7.2%,P < 0.001)。卢瑟福分类有效地预测了主要不良结局,在特定分类转换时显著增加表明存在风险分层的关键阈值。对于较高分类可能需要早期干预。这些发现支持将其用作术前规划和患者咨询中有价值的预后工具。

结论

本研究验证了卢瑟福分类作为预测CLTI患者不良结局的有效工具。较高分类与并发症增加之间的明确相关性支持其在临床决策、风险分层以及确定手术干预最佳时机方面的应用。

相似文献

1
Association of Chronic Limb Ischemia Rutherford Classification with Clinical Outcomes Following Lower Extremity Revascularization.慢性肢体缺血的卢瑟福分类与下肢血管重建术后临床结局的关联
Ann Vasc Surg. 2025 Apr;113:227-234. doi: 10.1016/j.avsg.2025.01.020. Epub 2025 Jan 27.
2
The Comorbidity-Polypharmacy Score as a Predictive Tool of Survival and Limb Salvage in Patients Undergoing Lower Limb Revascularization Procedures for Chronic Limb-Threatening Ischemia.合并症-多重用药评分作为慢性肢体威胁性缺血患者下肢血管重建手术生存和保肢预测工具。
Ann Vasc Surg. 2025 Jan;110(Pt A):423-431. doi: 10.1016/j.avsg.2024.09.061. Epub 2024 Oct 18.
3
Real-world application of Wound, Ischemia, and foot Infection scores in peripheral arterial disease patients.在周围动脉疾病患者中应用伤口、缺血和足部感染评分的实际情况。
J Vasc Surg. 2024 Oct;80(4):1216-1223. doi: 10.1016/j.jvs.2024.04.071. Epub 2024 May 7.
4
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial.BEST-CLI试验中慢性肾脏病患者慢性肢体威胁性缺血血运重建的结果
J Vasc Surg. 2025 Apr;81(4):945-956.e3. doi: 10.1016/j.jvs.2024.12.128. Epub 2025 Jan 23.
5
Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.血管外科学会伤口、缺血和足部感染(WIfI)分类系统对首次下肢血运重建术后的预测能力。
J Vasc Surg. 2017 Mar;65(3):695-704. doi: 10.1016/j.jvs.2016.09.055. Epub 2017 Jan 7.
6
The impact of travel distance in patient outcomes following revascularization for chronic limb-threatening ischemia.交通距离对慢性肢体威胁性缺血血运重建后患者结局的影响。
J Vasc Surg. 2024 Dec;80(6):1766-1775.e3. doi: 10.1016/j.jvs.2024.07.026. Epub 2024 Jul 16.
7
The Impact of Completion Angiography on Outcomes of Infrainguinal Lower Extremity Bypass for Chronic Limb-Threatening Ischemia.完成血管造影对慢性肢体威胁性缺血的股腘以下下肢旁路手术结局的影响。
Ann Vasc Surg. 2025 May;114:192-202. doi: 10.1016/j.avsg.2025.01.048. Epub 2025 Mar 5.
8
Validation of BEST-CLI among patients undergoing primary bypass or angioplasty with or without stenting for chronic limb-threatening ischemia.在接受初次搭桥或血管成形术(无论是否置入支架)治疗慢性肢体威胁性缺血的患者中对BEST-CLI进行验证。
J Vasc Surg. 2025 May;81(5):1138-1147.e2. doi: 10.1016/j.jvs.2025.01.009. Epub 2025 Jan 16.
9
Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial.在BEST-CLI试验中,严重创伤、缺血和足部感染阶段与不良预后相关。
J Vasc Surg. 2025 Mar;81(3):720-729.e1. doi: 10.1016/j.jvs.2024.11.027. Epub 2024 Dec 3.
10
Validation of the Global Limb Anatomic Staging System in first-time lower extremity revascularization.全球肢体解剖分期系统在首次下肢血运重建中的验证。
J Vasc Surg. 2021 May;73(5):1683-1691.e1. doi: 10.1016/j.jvs.2020.08.151. Epub 2020 Oct 20.

本文引用的文献

1
The impact of sex on platelet responses to aspirin in patients with peripheral artery disease.性别对周围动脉疾病患者血小板对阿司匹林反应的影响。
Am J Hematol. 2024 Apr;99 Suppl 1(Suppl 1):S6-S12. doi: 10.1002/ajh.27258. Epub 2024 Feb 23.
2
Predicting Arterial Thrombotic Events Following Peripheral Revascularization Using Objective Viscoelastic Data.利用客观黏弹性数据预测外周血运重建后的动脉血栓事件。
J Am Heart Assoc. 2023 Jan 3;12(1):e027790. doi: 10.1161/JAHA.122.027790. Epub 2022 Dec 24.
3
Sex Differences in Peripheral Artery Disease.外周血管疾病的性别差异。
Circ Res. 2022 Feb 18;130(4):496-511. doi: 10.1161/CIRCRESAHA.121.320702. Epub 2022 Feb 17.
4
Peripheral Artery Disease: A Comprehensive Updated Review.外周动脉疾病:全面更新综述。
Curr Probl Cardiol. 2022 Nov;47(11):101082. doi: 10.1016/j.cpcardiol.2021.101082. Epub 2021 Dec 11.
5
Disparities in Peripheral Artery Disease Hospitalizations Identified Among Understudied Race-Ethnicity Groups.在研究较少的种族/族裔群体中发现外周动脉疾病住院治疗存在差异。
Front Cardiovasc Med. 2021 May 24;8:692236. doi: 10.3389/fcvm.2021.692236. eCollection 2021.
6
Risk Stratification for 2-Year Mortality in Patients with Chronic Limb-Threatening Ischemia Undergoing Endovascular Therapy.慢性肢体严重缺血患者血管内治疗后 2 年死亡率的风险分层。
J Atheroscler Thromb. 2021 May 1;28(5):477-482. doi: 10.5551/jat.57711. Epub 2020 Jul 23.
7
Peripheral Artery Disease: Past, Present, and Future.外周动脉疾病:过去、现在与未来。
Am J Med. 2019 Oct;132(10):1133-1141. doi: 10.1016/j.amjmed.2019.04.043. Epub 2019 May 29.
8
Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment.下肢外周动脉疾病:诊断与治疗。
Am Fam Physician. 2019 Mar 15;99(6):362-369.
9
Update on peripheral artery disease: Epidemiology and evidence-based facts.外周动脉疾病最新进展:流行病学及循证事实
Atherosclerosis. 2018 Aug;275:379-381. doi: 10.1016/j.atherosclerosis.2018.05.033. Epub 2018 May 22.
10
Epidemiology of peripheral artery disease.外周动脉疾病的流行病学。
Circ Res. 2015 Apr 24;116(9):1509-26. doi: 10.1161/CIRCRESAHA.116.303849.